168 related articles for article (PubMed ID: 31807797)
21. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.
Qiu H; Novikov A; Vallon V
Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28099783
[TBL] [Abstract][Full Text] [Related]
22. Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study.
Kim YG; Han SJ; Kim DJ; Lee KW; Kim HJ
Cardiovasc Diabetol; 2018 Jun; 17(1):91. PubMed ID: 29935543
[TBL] [Abstract][Full Text] [Related]
23. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis.
Umapathysivam MM; Morgan B; Inglis JM; Meyer E; Liew D; Thiruvenkatarajan V; Jesudason D
JAMA Netw Open; 2024 Mar; 7(3):e242744. PubMed ID: 38497966
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.
Kosiborod M; Lam CSP; Kohsaka S; Kim DJ; Karasik A; Shaw J; Tangri N; Goh SY; Thuresson M; Chen H; Surmont F; Hammar N; Fenici P;
J Am Coll Cardiol; 2018 Jun; 71(23):2628-2639. PubMed ID: 29540325
[TBL] [Abstract][Full Text] [Related]
25. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
[TBL] [Abstract][Full Text] [Related]
26. [Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports].
Breuer TGK; Kampmann K; Wutzler A; Steinfort C; Uhl W; Schmidt WE; Meier JJ
Internist (Berl); 2018 Mar; 59(3):282-287. PubMed ID: 28864828
[TBL] [Abstract][Full Text] [Related]
27. Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials.
Patoulias D; Stavropoulos K; Imprialos K; Katsimardou A; Kalogirou MS; Koutsampasopoulos K; Zografou I; Papadopoulos C; Karagiannis A; Doumas M
Diabetes Res Clin Pract; 2019 Dec; 158():107927. PubMed ID: 31733280
[TBL] [Abstract][Full Text] [Related]
28. A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition.
Sanusi I; Sarnowski A; Russell-Jones D; Forni LG
J Crit Care; 2020 Jun; 57():19-22. PubMed ID: 32007835
[TBL] [Abstract][Full Text] [Related]
29. Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor.
Miyauchi M; Toyoda M; Fukagawa M
Intern Med; 2017; 56(13):1673-1678. PubMed ID: 28674356
[TBL] [Abstract][Full Text] [Related]
30. Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Perry RJ; Rabin-Court A; Song JD; Cardone RL; Wang Y; Kibbey RG; Shulman GI
Nat Commun; 2019 Feb; 10(1):548. PubMed ID: 30710078
[TBL] [Abstract][Full Text] [Related]
31. A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
Singh S; Rushakoff RJ; Neinstein AB
J Diabetes Sci Technol; 2019 May; 13(3):605-606. PubMed ID: 30931610
[No Abstract] [Full Text] [Related]
32. [Euglycemic Diabetic Ketoacidosis Caused by a Sodium-glucose Co-transporter (SGLT) 2 Inhibitor after Coronary Artery Bypass Grafting].
Kameda Y; Kato M; Inoue B; Yamazaki S; Sahara N; Aoki T; Nagashima Y; Nemoto N; Anzai H; Araki W; Kobayashi N
Kyobu Geka; 2019 May; 72(5):354-357. PubMed ID: 31268032
[TBL] [Abstract][Full Text] [Related]
33. Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus.
Kumar S; Khatik GL; Mittal A
Mini Rev Med Chem; 2020; 20(3):170-182. PubMed ID: 32134370
[TBL] [Abstract][Full Text] [Related]
34. Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials.
Monami M; Nreu B; Zannoni S; Lualdi C; Mannucci E
Diabetes Res Clin Pract; 2017 Aug; 130():53-60. PubMed ID: 28570924
[TBL] [Abstract][Full Text] [Related]
35. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Danne T; Garg S; Peters AL; Buse JB; Mathieu C; Pettus JH; Alexander CM; Battelino T; Ampudia-Blasco FJ; Bode BW; Cariou B; Close KL; Dandona P; Dutta S; Ferrannini E; Fourlanos S; Grunberger G; Heller SR; Henry RR; Kurian MJ; Kushner JA; Oron T; Parkin CG; Pieber TR; Rodbard HW; Schatz D; Skyler JS; Tamborlane WV; Yokote K; Phillip M
Diabetes Care; 2019 Jun; 42(6):1147-1154. PubMed ID: 30728224
[TBL] [Abstract][Full Text] [Related]
36. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
[TBL] [Abstract][Full Text] [Related]
37. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials.
Dicembrini I; Nreu B; Mannucci E; Monami M
Diabetes Obes Metab; 2019 Aug; 21(8):1871-1877. PubMed ID: 30972917
[TBL] [Abstract][Full Text] [Related]
38. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
[TBL] [Abstract][Full Text] [Related]
39. Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Blau JE; Tella SH; Taylor SI; Rother KI
Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28736981
[TBL] [Abstract][Full Text] [Related]
40. Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy.
Palmer BF; Clegg DJ
Clin J Am Soc Nephrol; 2021 Aug; 16(8):1284-1291. PubMed ID: 33563658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
